Table 4 Univariate and multivariate linear model of E/e′ ratio in primary aldosteronism
Variables | Univariate correlation coefficient | P-value | Multivariate beta-coefficient (s.e.m.) | P-value |
|---|---|---|---|---|
Age (years) | 0.483 | <0.001 | 0.416 (0.027) | <0.001 |
Sex | −0.131 | 0.11 | ||
Body mass index (kg m−2) | 0.115 | 0.18 | ||
Hypertension course (years) | 0.217 | 0.017 | ||
Diabetes mellitus | 0.129 | 0.018 | ||
Systolic blood pressure, 24-h (mm Hg) | 0.348 | <0.001 | 0.238 (0.023) | 0.016 |
Diastolic blood pressure, 24-h (mm Hg) | −0.041 | 0.43 | ||
Heart rate, 24-h (BPM) | −0.188 | 0.07 | ||
Serum creatinine (μmol l−1) | 0.136 | 0.09 | ||
Serum potassium (mmol l−1) | −0.211 | 0.007 | −0.201 (0.807) | 0.036 |
Urinary potassium (mmol per 24 h) | −0.034 | 0.38 | ||
Plasma aldosterone (pg ml−1) | −0.044 | 0.34 | ||
Plasma renin activity (ng ml−1 per h) | −0.071 | 0.25 | ||
Serum sodium (mmol l−1) | −0.012 | 0.45 | ||
MR inhibitor (%) | −0.177 | 0.056 | ||
CCB (%) | 0.123 | 0.14 | ||
ACE-I or ARB (%) | 0.100 | 0.19 | ||
Adrenoceptor blockers (%) | −0.026 | 0.41 | ||
Beta-blocker (%) | 0.020 | 0.43 | ||
Diuretic (%) | 0.159 | 0.08 |
